Aphria Inc. (NYSE: APHA) reported second-quarter 2021 earnings results on Thursday. Revenues were C$160.5 million, an increase of 33% compared to the previous year.
On an adjusted basis, the company reported earnings of C$0.01 per share, compared to a loss of C$0.19 per share last year. Unadjusted net loss widened to C$120.59 million from C$7.93 million, while loss per share rose to C$0.42 from C$0.03 last year.
“We are pleased with our second-quarter results which reflect the strength of our diversified global cannabis and consumer packaged goods businesses,” said Irwin D. Simon, Chairman, and Chief Executive Officer.
The company has signed an agreement to combine with Tilray, Inc. to have the world’s largest global cannabis company based on clean financial valuations.
Aphria’s stock closed at $9.43 on Wednesday evening. showing an increase of 6%.
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
